Inovio Biomedical Corp., of Blue Bell, Pa., expanded its license agreement with the University of Pennsylvania, adding exclusive worldwide licenses for technology and intellectual property for DNA vaccines against pandemic influenza, Chikungunya and foot-and-mouth disease.